| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,495 |
12,073 |
$434K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,700 |
6,340 |
$247K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,204 |
1,857 |
$215K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,783 |
3,754 |
$35K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,608 |
6,869 |
$35K |
| 87631 |
|
373 |
312 |
$31K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
486 |
431 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,339 |
586 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
318 |
250 |
$7K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
1,416 |
1,182 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
852 |
719 |
$6K |
| 90688 |
|
862 |
779 |
$6K |
| 1160F |
|
15,357 |
10,352 |
$4K |
| 1159F |
|
15,426 |
10,369 |
$4K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,309 |
1,115 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
365 |
323 |
$3K |
| 81001 |
|
2,056 |
1,805 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
56 |
53 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
397 |
328 |
$2K |
| 3078F |
|
7,448 |
5,413 |
$2K |
| 3008F |
|
13,177 |
8,967 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
3,200 |
2,827 |
$2K |
| 3074F |
|
7,187 |
5,219 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
56 |
54 |
$2K |
| 3079F |
|
3,846 |
3,012 |
$2K |
| 3077F |
|
3,623 |
2,645 |
$2K |
| 3080F |
|
1,960 |
1,489 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
766 |
592 |
$899.70 |
| 3075F |
|
2,409 |
1,937 |
$838.54 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
12 |
$834.60 |
| 90756 |
|
92 |
83 |
$809.39 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
183 |
136 |
$667.53 |
| 81003 |
|
693 |
550 |
$544.80 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,231 |
1,869 |
$486.78 |
| 90686 |
|
50 |
41 |
$373.26 |
| 93000 |
|
16 |
13 |
$140.45 |
| G0008 |
Administration of influenza virus vaccine |
729 |
657 |
$96.60 |
| 82962 |
|
58 |
52 |
$68.40 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
15 |
14 |
$53.30 |
| 90694 |
|
43 |
37 |
$2.66 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
12,386 |
8,682 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
4,570 |
3,459 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
11,773 |
8,611 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
20,099 |
14,152 |
$0.00 |
| 4004F |
|
4,881 |
3,382 |
$0.00 |
| 1158F |
|
109 |
96 |
$0.00 |
| 90662 |
|
19 |
16 |
$0.00 |
| 90653 |
|
15 |
13 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
4,688 |
3,250 |
$0.00 |
| 1036F |
|
13,236 |
9,391 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
13,725 |
9,978 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
4,661 |
3,234 |
$0.00 |
| 99000 |
|
169 |
153 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
12,456 |
8,795 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
4,331 |
3,121 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
2,412 |
1,882 |
$0.00 |
| 3044F |
|
29 |
25 |
$0.00 |
| G9664 |
Patients who are currently statin therapy users or received an order (prescription) for statin therapy |
109 |
91 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
96 |
85 |
$0.00 |
| 4010F |
|
47 |
42 |
$0.00 |
| 1170F |
|
114 |
101 |
$0.00 |
| 1126F |
|
34 |
31 |
$0.00 |
| 3061F |
|
42 |
38 |
$0.00 |